299 related articles for article (PubMed ID: 29572286)
41. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.
Htoo PT; Stürmer T; Jonsson-Funk M; Pate V; Simpson RJ; Lund JL
Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009
[TBL] [Abstract][Full Text] [Related]
42. Impact of Antihypertensive Drug Class on Outcomes in SPRINT.
DeCarolis DD; Gravely A; Olney CM; Ishani A
Hypertension; 2022 May; 79(5):1112-1121. PubMed ID: 35259925
[TBL] [Abstract][Full Text] [Related]
43. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
[TBL] [Abstract][Full Text] [Related]
44. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study.
Ruths S; Bakken MS; Ranhoff AH; Hunskaar S; Engesæter LB; Engeland A
BMC Geriatr; 2015 Dec; 15():153. PubMed ID: 26626043
[TBL] [Abstract][Full Text] [Related]
45. Antihypertensive drug therapies and the risk of ischemic stroke.
Klungel OH; Heckbert SR; Longstreth WT; Furberg CD; Kaplan RC; Smith NL; Lemaitre RN; Leufkens HG; de Boer A; Psaty BM
Arch Intern Med; 2001 Jan; 161(1):37-43. PubMed ID: 11146696
[TBL] [Abstract][Full Text] [Related]
46. Thiazide diuretics: first-line therapy for hypertension.
Ramsay LE; Yeo WW; Jackson PR
J Hypertens Suppl; 1992 Jun; 10(3):S29-32; discussion S32-3. PubMed ID: 1353112
[TBL] [Abstract][Full Text] [Related]
47. Comparative effectiveness of antihypertensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study.
Bronsert MR; Henderson WG; Valuck R; Hosokawa P; Hammermeister K
J Am Board Fam Med; 2013; 26(5):529-38. PubMed ID: 24004705
[TBL] [Abstract][Full Text] [Related]
48. Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.
Osula D; Wu B; Schesing K; Das SR; Moss E; Alvarez K; Clark C; Halm EA; Brown NJ; Vongpatanasin W
J Am Heart Assoc; 2022 Oct; 11(19):e027099. PubMed ID: 36193931
[TBL] [Abstract][Full Text] [Related]
49. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study.
Lapi F; Azoulay L; Yin H; Nessim SJ; Suissa S
BMJ; 2013 Jan; 346():e8525. PubMed ID: 23299844
[TBL] [Abstract][Full Text] [Related]
50. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
51. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Wamil M; Majert J; Smith Byrne K; Sundström J; Teo K; Davis BR; Chalmers J; Pepine CJ; Dehghan A; Bennett DA; Smith GD; Rahimi K;
Lancet; 2021 Nov; 398(10313):1803-1810. PubMed ID: 34774144
[TBL] [Abstract][Full Text] [Related]
52. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
[TBL] [Abstract][Full Text] [Related]
53. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
54. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
Smith SM; Winterstein AG; Gurka MJ; Walsh MG; Keshwani S; Libby AM; Hogan WR; Pepine CJ; Cooper-DeHoff RM
J Am Heart Assoc; 2023 Jan; 12(1):e026652. PubMed ID: 36565195
[TBL] [Abstract][Full Text] [Related]
55. [Treatment of patients with arterial hypertension in clinical practice in 2010-2020 (according to the national register of hypertension)].
Aksenova AV; Oschepkova EV; Chazova IE
Ter Arkh; 2022 Jan; 94(1):9-17. PubMed ID: 36286915
[TBL] [Abstract][Full Text] [Related]
56. Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2016 Oct; 34(10):1921-32. PubMed ID: 27454050
[TBL] [Abstract][Full Text] [Related]
57. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
Volpe M; Tocci G
Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
[TBL] [Abstract][Full Text] [Related]
58. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
59. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).
Ambrosius WT; Sink KM; Foy CG; Berlowitz DR; Cheung AK; Cushman WC; Fine LJ; Goff DC; Johnson KC; Killeen AA; Lewis CE; Oparil S; Reboussin DM; Rocco MV; Snyder JK; Williamson JD; Wright JT; Whelton PK;
Clin Trials; 2014 Oct; 11(5):532-46. PubMed ID: 24902920
[TBL] [Abstract][Full Text] [Related]
60. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
Vijan S; Hayward RA
Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]